KASHIWAGI; Hirotaka

Patent Applications and Registrations

Patent applications and USPTO patent grants for KASHIWAGI; Hirotaka.The latest application filed is for "asphalt composition".

Company Profile

3.9.12

KASHIWAGI; Hirotaka - Wakayama-shi JP
KASHIWAGI; Hirotaka - Shizuoka JP
Kashiwagi; Hirotaka - Gotenba N/A JP
Kashiwagi, Hirotaka - Gotenba-shi JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Asphalt Composition App 20210395529 - KAKIUCHI; Hiroki ; et al.	2021-12-23
Pyrazolopyridine Derivative Having Glp-1 Receptor Agonist Effect App 20210017176 - YOSHINO; Hitoshi ; et al.	2021-01-21
Pyrazolopyridine derivative having GLP-1 receptor agonist effect Grant 10,858,356 - Yoshino , et al. December 8, 2	2020-12-08
Pyrazolopyridine Derivative Having Glp-1 Receptor Agonist Effect App 20190225604 - YOSHINO; Hitoshi ; et al.	2019-07-25
Dihydropyridazine-3,5-dione derivative and pharmaceuticals containing the same Grant 9,499,553 - Ohtake , et al. November 22, 2	2016-11-22
Dihydropyridazine-3,5-dione Derivative And Pharmaceuticals Containing The Same App 20160002251 - OHTAKE; Yoshihito ; et al.	2016-01-07
Process for the synthesis of vitamin D compounds and intermediates for the synthesis of the compounds Grant 9,221,753 - Kashiwagi , et al. December 29, 2	2015-12-29
Coumarin derivatives useful as TNF.alpha. inhibitors Grant 7,994,318 - Cheng , et al. August 9, 2	2011-08-09
Vitamin D-like compound Grant 7,935,688 - Takahashi , et al. May 3, 2	2011-05-03
Vitamin-d-like Compounds App 20110060146 - TAKAHASHI; TADAKATSU ; et al.	2011-03-10
Coumarin derivatives useful as TNF.alpha. inhibitors Grant 7,872,142 - Cheng , et al. January 18, 2	2011-01-18
Coumarin Derivatives Useful As Tnf Alpha Inhibitors App 20100197917 - Cheng; Jie Fei ; et al.	2010-08-05
Coumarin Derivatives Useful As Tnf Alpha Inhibitors App 20100174076 - Cheng; Jie Fei ; et al.	2010-07-08
Coumarin derivatives useful as TNF.alpha. inhibitors Grant 7,709,664 - Cheng , et al. May 4, 2	2010-05-04
Vitamin D-like Compound App 20090137609 - Takahashi; Tadakatsu ; et al.	2009-05-28
Process for the synthesis of vitamin d compounds and intermediates for the synthesis of the compounds App 20070135394 - Kashiwagi; Hirotaka ; et al.	2007-06-14
Coumarin derivatives useful as TNF.alpha. inhibitors Grant 7,026,491 - Cheng , et al. April 11, 2	2006-04-11
Bisphenyl compounds useful as vitamin D3 receptor agonists App 20060025474 - Wallace; David ; et al.	2006-02-02
Coumarin derivatives useful as TNFalpha inhibitors App 20060020138 - Cheng; Jie Fei ; et al.	2006-01-26
Pharmaceutical preparations for treatment of type II diabetes and methods for treatment of type II diabetes App 20040063780 - Matsuoka, Hiroharu ; et al.	2004-04-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.